[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359183-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-359183-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","risk-factors-associated-with-false-positive-fecal-immunochemical-test-results-in-colorectal-cancer-screening","Risk factors associated with false-positive fecal immunochemical test results in colorectal cancer screening","","Fecal immunochemical test (FIT)-based colorectal cancer screening can yield false-positive results, yet the determinants of these outcomes remain insufficiently characterized. This prospective study enrolled 929 adults aged 50+ at Qilu Hospital between April 2020 and April 2021. Using a cut-off of ≥10 μg/g from two stool samples and subsequent gastroscopy and colonoscopy, false-positive FITs were defined as FIT-positive without advanced neoplasia. After confounder adjustment, male sex, colorectal inflammation, three or more non-advanced adenomas, and gastric cancer increased false-positive risk, while routine upper endoscopy was not recommended, suggesting conditional evaluation when additional factors exist.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/risk-factors-associated-with-false-positive-fecal-immunochemical-test-results-in-colorectal-cancer-screening/359183/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/risk-factors-associated-with-false-positive-fecal-immunochemical-test-results-in-colorectal-cancer-screening/359183.png","ImageObject",300,407,{"name":42,"@type":43},"Mia  ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were false-positive FIT results defined in this study?","Question",{"text":63,"@type":64},"False-positive results were FIT-positive cases in which no advanced neoplasia was detected on subsequent colonoscopy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What FIT threshold determined a positive result?",{"text":68,"@type":64},"A two-sample FIT was used, and ≥10 μg/g in either stool sample was considered positive.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were associated with a higher risk of false-positive FIT results after adjustment?",{"text":72,"@type":64},"Male sex, colorectal inflammation, having three or more non-advanced adenomas, and gastric cancer were associated with higher false-positive risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},359183,1790184099,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nRisk factors associated with falsepositive fecal immunochemical test results in colorectal cancer screening  \nIqtida Ahmed Mirza1,2,3, Fan-Yi Meng4, Zhongxue Han1,2,3, Pei-Zhu Wang1,2,3, Yue-Yue Li1,2,3, Yan Zhang1,2,3, Ming-Jun Ma1,2,3, Xiu-Li Zuo1,2,3, Yan-Qing Li1,2,3􀀍 & Ru-Chen Zhou1,2,3􀀍  \nFecal immunochemical test (FIT)-based screening has been recommended as an option for population colorectal cancer (CRC) screening. However, the studies on factors associated with false-positive FIT results are still limited. To identify the clinical and endoscopic factors associated with false-positive results of FIT for advanced neoplasia (AN) and to evaluate whether false-positive FIT results would be indicative of other digestive tract diseases. We prospectively enrolled 929 participants aged 50 years or older at Qilu Hospital of Shandong University between April 2020 and April 2021. The two-sample FIT was used in this study and ≥ 10 μg/g in either of two stool samples was regarded as the positive  \nFIT result. All these participants underwent subsequent gastroscopy and colonoscopy. False positive FIT results were defined as positive FITs without AN detected in colonoscopies. With a cut-off value of 10 µg/g, the positive rate of FIT was 16.0%. For detecting AN, the sensitivity and specificity were 64.6% and 87.6%, respectively. After adjusting confounding factors, male (OR = 1.61; 95% CI, 1.05–2.48;  \nP = 0.030), colorectal inflammation (OR = 2.99; 95% CI, 1.38–6.04; P = 0.003), presence of three or more non-advanced adenomas (OR = 1.78; 95% CI, 1.11–2.82; P = 0.015) and gastric cancer (OR = 11.33; 95% CI, 2.40–59.52; P = 0.002) were associated with higher risk of false-positive FIT results. Although the FIT results may be false-positive for detecting AN, they may still suggest medical issues that warrant closer medical follow-up and intervention. Meanwhile, routine upper endoscopy investigation for false positive patients was not recommended. Upper endoscopy may be considered conditionally in FITpositive/AN-negative patients with additional risk factors. Large-scale research is required to clarify this issue. ([ClinicalTrials.gov](ClinicalTrials.gov) ID: NCT04454099)  \nTrial identification number: ClinicalTrials.gov ID: NCT04454099 (URL: https://clinicaltrials.gov/ct2/show /NCT04454099) registered on July 1, 2020.  \nKeywords False positive, Fecal occult blood test, Mass screening, Colorectal neoplasms, Gastric cancer  \nColorectal cancer (CRC) is one of the most leading causes of tumor-associated mortality worldwide. It is the most commonly diagnosed cancer of the gastrointestinal tract1. However, survival rates of CRC differ significantly between early and advanced CRC patients2. And the development from advanced adenoma (AA) to advanced CRC takes a long time3, suggesting that CRC is a preventable cancer type. Therefore, early detection and removal of precursor lesions could effectively reduce CRC-associated mortality4,5.  \nStool-based tests have been recommended as options for population CRC screening. In many regions worldwide, fecal immunochemical test (FIT)-based screening for CRC has been implemented and acquired good effect6–8. Some studies showed that FIT-based screening programs reduced cancer-associated mortality  \n1Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China. 2Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, No. 107, Wenhuaxi Road, Jinan 250012, Shandong, China. 3Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, Shandong, China. 4Department of Gastroenterology and Hepatology, Tianjin Key Laboratory of Digestive Diseases, General Hospital, Tianjin Medical University, National Key Clinical Specialty, Tianjin Institute of Digestive Diseases, Tianjin 300052, China. 􀀍 email: [liyanqing@sdu.edu.cn","cbCait8enO2gU0pB","https://ap.wps.com/l/cbCait8enO2gU0pB","pdf",1567646,"English","# Introduction\n## Rationale for FIT-based colorectal screening\n## Impact of false-positive FIT results\n# Methods\n## Study design and participants\n## FIT threshold and definitions\n## Endoscopic follow-up\n# Results\n## Diagnostic performance\n## Factors associated with false-positive FIT\n## Guidance on upper endoscopy","[{\"question\":\"How were false-positive FIT results defined in this study?\",\"answer\":\"False-positive results were FIT-positive cases in which no advanced neoplasia was detected on subsequent colonoscopy.\"},{\"question\":\"What FIT threshold determined a positive result?\",\"answer\":\"A two-sample FIT was used, and ≥10 μg/g in either stool sample was considered positive.\"},{\"question\":\"Which factors were associated with a higher risk of false-positive FIT results after adjustment?\",\"answer\":\"Male sex, colorectal inflammation, having three or more non-advanced adenomas, and gastric cancer were associated with higher false-positive risk.\"}]","Risk factors associated with false-positive fecal immunochemical test results in colorectal cancer screening | PDF",1790136348,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25c8b91f11e709fb56f37efe54098efd.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02218bc7476fcecff015358a5f28db0b.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f532a1da46a8dfecd68ef2990433299.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2db9e5ad7a0e527173dd2891cc3b75c.webp",980,1287]